合計 50 件の最近のインサイダー取引記録が記録されています Adial Pharmaceuticals, Inc. (ADIL), 内訳は 46 件の買い および 1 件の売り. インサイダー買い総額は $2.6M インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Claiborne Cary J, Goodman Tony, Anderson J. Kermit. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ADIL
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-05-29 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
138,000 |
$0.69 |
$94.94K |
138,000 |
| 2025-05-29 |
Goodman Tony |
Chief Operating Officer |
RSU 付与（制限付株式） |
94,000 |
$0.69 |
$64.67K |
94,000 |
| 2025-05-29 |
Anderson J. Kermit |
Director |
RSU 付与（制限付株式） |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Schuyler Kevin |
Director |
RSU 付与（制限付株式） |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Gilliland Robertson H. |
Director |
RSU 付与（制限付株式） |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Newman James W. Jr. |
Director |
RSU 付与（制限付株式） |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Shah Vinay |
Chief Financial Officer |
RSU 付与（制限付株式） |
9,000 |
$0.69 |
$6.19K |
9,000 |
| 2024-12-05 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
350,000 |
$1.15 |
$402.5K |
350,000 |
| 2024-11-16 |
Shah Vinay |
Officer |
不明 |
- |
- |
- |
- |
| 2024-11-16 |
Shah Vinay |
Chief Financial Officer |
RSU 付与（制限付株式） |
40,000 |
$1.06 |
$42.4K |
40,000 |
| 2024-03-25 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
60,000 |
$1.35 |
$81K |
60,000 |
| 2024-03-25 |
Goodman Tony |
Chief Operating Officer |
RSU 付与（制限付株式） |
42,000 |
$1.35 |
$56.7K |
42,000 |
| 2024-03-25 |
Anderson J. Kermit |
Director |
RSU 付与（制限付株式） |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Truluck Joseph |
Chief Financial Officer |
RSU 付与（制限付株式） |
25,000 |
$1.35 |
$33.75K |
25,000 |
| 2024-03-25 |
Schuyler Kevin |
Director |
RSU 付与（制限付株式） |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Gilliland Robertson H. |
Director |
RSU 付与（制限付株式） |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Newman James W. Jr. |
Director |
RSU 付与（制限付株式） |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2023-09-29 |
Schuyler Kevin |
Director |
情報に基づく買い |
700 |
$2.74 |
$1.92K |
700 |
| 2023-05-23 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
300,000 |
$0.30 |
$90.75K |
300,000 |
| 2023-05-23 |
Goodman Tony |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Anderson J. Kermit |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Stilley William B. Iii |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Truluck Joseph |
Chief Financial Officer |
RSU 付与（制限付株式） |
125,000 |
$0.30 |
$37.81K |
125,000 |
| 2023-05-23 |
Schuyler Kevin |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Gilliland Robertson H. |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Newman James W. Jr. |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Johnson Bankole A. |
Director |
RSU 付与（制限付株式） |
40,000 |
$0.30 |
$12.1K |
40,000 |
| 2022-12-30 |
Stilley William B. Iii |
Director |
株式返還 |
166,667 |
- |
- |
1,020,979 |
| 2022-09-20 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
75,000 |
$0.42 |
$31.52K |
1,100,000 |
| 2022-09-19 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
25,000 |
$0.43 |
$10.74K |
1,025,000 |
| 2022-08-22 |
Stilley William B. Iii |
Director |
RSU 付与（制限付株式） |
100,000 |
$0.56 |
$55.5K |
100,000 |
| 2022-08-18 |
Claiborne Cary J |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,000,000 |
- |
- |
1,000,000 |
| 2022-06-27 |
Goodman Tony |
Director |
RSU 付与（制限付株式） |
25,000 |
- |
- |
25,000 |
| 2022-02-23 |
Claiborne Cary J |
Chief Operating Officer |
RSU 付与（制限付株式） |
6,667 |
$2.00 |
$13.33K |
6,667 |
| 2022-02-23 |
Goodman Tony |
Director |
RSU 付与（制限付株式） |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Anderson J. Kermit |
Director |
RSU 付与（制限付株式） |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Stilley William B. Iii |
Chief Executive Officer |
RSU 付与（制限付株式） |
250,000 |
- |
- |
1,187,646 |
| 2022-02-23 |
Truluck Joseph |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$2.00 |
$200K |
100,000 |
| 2022-02-23 |
Schuyler Kevin |
Director |
RSU 付与（制限付株式） |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Johnson Bankole A. |
Chief Medical Officer |
RSU 付与（制限付株式） |
35,000 |
$2.00 |
$70K |
35,000 |
| 2022-02-23 |
Gilliland Robertson H. |
Director |
RSU 付与（制限付株式） |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Newman James W. Jr. |
Director |
RSU 付与（制限付株式） |
40,000 |
$2.00 |
$80K |
40,000 |
| 2021-12-30 |
Newman James W. Jr. |
Director |
情報に基づく買い |
10,000 |
$2.66 |
$26.6K |
20,000 |
| 2021-12-23 |
Schuyler Kevin |
10 Percent Owner |
贈与（送付） |
90,000 |
$6.25 |
$562.5K |
- |
| 2021-12-07 |
Claiborne Cary J |
Chief Operating Officer |
RSU 付与（制限付株式） |
130,000 |
$2.77 |
$360.1K |
130,000 |
| 2021-11-30 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
情報に基づく買い |
10,600 |
$2.75 |
$29.18K |
937,646 |
| 2021-11-29 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
情報に基づく買い |
10,000 |
$2.59 |
$25.89K |
927,046 |
| 2021-11-26 |
Newman James W. Jr. |
Director |
情報に基づく買い |
10,000 |
$2.85 |
$28.5K |
34,475 |
| 2021-11-02 |
Claiborne Cary J |
Director |
不明 |
- |
- |
- |
- |
| 2021-11-02 |
Claiborne Cary J |
Director |
RSU 付与（制限付株式） |
60,000 |
$3.15 |
$189K |
60,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
